Global Growth Opportunities in Glucose Monitoring Markets Remain Untapped in a Sagging Economy.Business Editors/Health/Medical Writers PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif.--(BUSINESS WIRE)--Feb. 17, 2004 An increasingly savvy consumer base coupled with the growing incidence of diabetes are spurring the growth of the glucose self-monitoring devices markets. With healthcare specialists and manufacturers investing resources towards creating awareness, there has been an increase in the demand for sophisticated, convenient and cost effective home glucose monitoring glucose monitoring Lab medicine The periodic evaluation of any analyte abnormal in Pts with DM, to assess short and long-term control with antiglycemic agents. See Glucose, Glycated hemoglobin. devices. New Strategic Analysis Service deliverable from Frost & Sullivan (http://www.healthcare.frost.com/), Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets, reveals that revenues in this industry totaled $5.04 billion in 2003 and is projected to reach $12.4 billion by 2010. If you are interested in a virtual brochure, which provides manufacturers, end-users and other industry participants an overview of the latest analysis of the Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets - then send an email to Danielle White Danielle Marie White (born February 2, 1992 in Cincinnati, Ohio) is an American singer who was raised in Bradenton, Florida. In 2003, White appeared on the reality television series American Juniors - Healthcare Media Relations Executive at dwhite@frost.com with the following information: your full name, company name, title, telephone number, fax number, and email. Upon receipt of the above information, an overview will be sent to you via e-mail. "The growth in self-monitoring has fuelled the emergence of new technologies. The new non-invasive or minimally invasive options on the horizon could revolutionize blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence self-monitoring in the years ahead. Perhaps the greatest challenge for manufacturers will be for new technologies to move from being adjunctive to the finger stick method to being viable stand-alone alternatives. Also, far more important than time to market, favorable pricing options hold the promise of high adoption rates," says Frost & Sullivan's Patient Monitoring Analyst Seemeen Mirza. Mr. John Simons John Simons is a British radio executive. He is currently the Group Programming Director for GMG Radio.[1] He began his career as a presenter in 1979.[1] He presented the Breakfast Show on Radio Tees from 1983 to 1985, where was also Head of Music. , Vice President of Worldwide Strategic Marketing at Becton Dickinson BD (NYSE: BDX), is a medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs 27,000 people in nearly 50 countries. & Company, highlights the role played by technology and system integration in facilitating diabetes management This article is about the management of diabetes mellitus. For more on the disease itself see diabetes mellitus. Diabetes is a chronic disease with no cure as of 2007. It is associated with an impaired glucose cycle, altering metabolism. , improving patient compliance as well as outcomes. "Advances in technology, specifically in system integration and information management, are among the key areas of focus in the BGM (blood glucose monitoring blood glucose monitoring Sugar monitoring Lab medicine The periodic testing of serum glucose in Pts known to have DM. See Bedside glucose monitoring, Beta cell implants, Diabetes, Glucometer, Glycosylated hemoglobin, Non-Invasive glucose monitoring. ) market. New devices with more sophisticated capabilities are emerging. At BD, in partnership with Medtronic Minimed, we are excited about our recent launch of the Paradigm Link(TM) Blood Glucose Monitor, the first BGM to communicate wirelessly with an insulin pump insulin pump n. A portable device for people with diabetes that injects insulin at programmed intervals in order to regulate blood sugar levels. . Not only do the devices contain memory of insulin infusion and BG values, but unique features of the Paradigm(R) insulin pumps can actually assist patients with their insulin therapy. In the long run, integrated devices like these can actually assist patients and health care providers with their diabetes management and in improving outcomes," notes Mirza. Frost & Sullivan's "Strategic Analysis Service (SAS (1) (SAS Institute Inc., Cary, NC, www.sas.com) A software company that specializes in data warehousing and decision support software based on the SAS System. Founded in 1976, SAS is one of the world's largest privately held software companies. See SAS System. )" is the newest tool aimed at equipping the C-level and Senior executives of global healthcare and life sciences companies with cutting edge research, strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , and structured advisory services advisory services advisory services provided to the public, in their capacity as owners and managers of animals, are an important part of veterinary science. They may be provided by government bureaux, by commercial companies who deal in pharmaceuticals or animals or animal . According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Dorman Followwill, VP of the Healthcare & Life Sciences practice at Frost & Sullivan, "This new service is in direct response to what the top executives are asking for - concise and detailed market analysis from a growth perspective, complete with a personalized one-on-one presentation from the consulting analyst who conducted the primary research. Additionally, as a part of this service, the client will have an opportunity to communicate directly with our consulting team on any issue related to the industry." Enhanced marketing and growth capabilities coupled with strategic leadership have become critical tools for companies striving to increase growth and profitability against a backdrop of shifting marketplace conditions. Utilizing the market opportunities landscape and then mapping that to corporate growth objectives are vital to growth strategy improving shareholder value and maximizing return on investment. The Strategic Analysis Service will provide a highly insightful analysis of the market opportunities landscape in a cost effective and efficient manner. As an added value Frost & Sullivan encourages one-on-one interaction between client and consultant via this service. Frost & Sullivan is a global leader in strategic growth consulting. This ongoing strategic analysis is part of the Patient Monitoring Subscription, which also includes market insights on U.S. Diabetes Glucose Monitoring Devices Markets, World Cardiovascular Monitoring Equipment Markets, U.S. External Defibrillators Markets and others. Frost & Sullivan also offers growth-consulting services to a variety of leading national and international companies. Interviews are available to the media. Strategic Analysis of World Diabetes Glucose Monitoring Devices Markets A727-56 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion